Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment.

scientific article published on 6 December 2017

Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CLAE.2017.11.004
P698PubMed publication ID29223649

P50authorRocio Herrero-VanrellQ39518488
Irene Teresa Molina MartínezQ70591035
P2093author name stringJosé Manuel Benítez-Del-Castillo
Duygu Acar
Miguel Gómez-Ballesteros
Manuel Guzmán-Navarro
P433issue1
P921main subjecteye diseaseQ3041498
P304page(s)93-96
P577publication date2017-12-06
P1433published inContact Lens and Anterior EyeQ15750495
P1476titleNovel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment.
P478volume41

Reverse relations

cites work (P2860)
Q99583099Crosslinked hyaluronic acid with liposomes and crocin for management symptoms of dry eye disease caused by moderate meibomian gland dysfunction
Q92824372Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits
Q92376227Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment
Q64252072Preparation and Characterization of New Liposomes. Bactericidal Activity of Cefepime Encapsulated into Cationic Liposomes

Search more.